Apellis Pharmaceuticals, Inc.APLSNASDAQ
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+54.1%
5Y CAGR+70.0%
Year-over-Year Change
Year-over-year earnings per share growth rate
3Y CAGR
+54.1%/yr
Annual compound
5Y CAGR
+70.0%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
14.2x
Strong expansion
Streak
2 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 111.25% |
| 2024 | 64.04% |
| 2023 | 27.64% |
| 2022 | 30.43% |
| 2021 | -92.59% |
| 2020 | 7.83% |
| 2019 | -112.82% |
| 2018 | -57.05% |
| 2017 | 0.67% |
| 2016 | 41.63% |